Medpace
- Market cap
- 16.87B
- P/E (TTM)i
- 35.50
- P/Bi
- 38.87
- EPSi
- 15.28
- Div yieldi
- 0.00%
- 52W posi
- 76%
Anonymous reader poll. Unscientific, not investment advice.
About Medpace
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
- Founded
- 1992
- CEO
- Mr. August J. Troendle, M.D.
- Employees
- 6,200
- Headquarters
- Cincinnati, Ohio, United States of America
- Fiscal year end
- 12-31
- Website
- medpace.com
Company profile
- Exchange
- US
- Symbol
- MEDP
- Market-cap rank
- #1015
- Listing date
- 2016-08-11
- Market cap
- 16.87B
- Float cap
- 13.69B
- Shares out
- 27.91M
- Float shares
- 22.66M
Sectors & themes
Quote time 2026-10-08 03:14:43 · For reference only, not investment advice and not tailored to your situation.